Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
11.37 USD | -3.64% | +1.07% | +49.21% |
05-13 | Baird Adjusts Price Target on Instil Bio to $32 From $54, Maintains Outperform Rating | MT |
05-10 | Instil Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+49.21% | 76.75M | |
+27.53% | 48.16B | |
-0.75% | 41.73B | |
+43.45% | 41.03B | |
-5.26% | 28.77B | |
+10.66% | 25.59B | |
-22.65% | 18.96B | |
+8.19% | 12.92B | |
+29.29% | 12.03B | |
-1.99% | 11.77B |
- Stock Market
- Equities
- TIL Stock
- News Instil Bio, Inc.
- Instill Bio to Cut US Workforce by 60%; Reprioritizes Clinical Program; Shares Down Pre-Bell